Literature DB >> 29515668

An unusual presentation of a more common disease entity.

Charlotte Van de Kerkhove1, Walter De Wever2, Eric K Verbeken3, Christophe Deroose4, Kris Nackaerts5.   

Abstract

Beware unusual presentations of more common disease entities, as in this interactive case report http://ow.ly/qj7f30eVFsp.

Entities:  

Year:  2018        PMID: 29515668      PMCID: PMC5831344          DOI: 10.1183/20734735.013417

Source DB:  PubMed          Journal:  Breathe (Sheff)        ISSN: 1810-6838


A 66-year-old, male patient with a 10-pack-year history of smoking was referred to the internal medicine consultation because of a 4-week history of fatigue, weakness, intermittent low-grade fever, appetite and weight loss, and a mild dry cough. His previous history was unremarkable and his physical examination was normal. Routine laboratory screening revealed leukocytosis (11.08×109 leukocytes per L), elevated C-reactive protein (72.1 mg⋅L−1) and erythrocyte sedimentation rate 57 mm⋅h−1. Analyses for rheumatoid factor, antinuclear antibodies, and cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies were all negative. Pulmonary function tests (static and dynamic volumes, flow–volume curve, and lung diffusion capacity) were within the predictive values. Chest radiography demonstrated bilateral hilar enlargement. The patient subsequently underwent a computed tomography (CT) scan of the chest (figure 1).
Figure 1

Chest CT.

Chest CT.

Task 1

Describe the imaging findings noted on the CT scan of the chest.

Answer 1

The images demonstrate a new spiculated lung nodule 2 cm in diameter in the left lower lobe (figure 1d). Hilar and mediastinal lymphadenopathies in positions 2R (figure 1a), 4L (figure 1b), 7 and 10L (figure 1c) are present. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) was performed, showing hypermetabolic activity of the focal lung lesion (figure 2d), and moderate-to-strong FDG-positive left and right paratracheal, subcarinal and hilar mediastinal lymph nodes (figure 2).
Figure 2

Fusion PET-CT.

Fusion PET-CT.

Task 2

What is your differential diagnosis and what is the most appropriate diagnostic step?

Answer 2

Lymph nodes may be enlarged for a variety of inflammatory, infectious or malignant reasons. Here, the differential diagnosis would be lung carcinoma, lymphoma, tuberculosis, sarcoidosis and organising pneumonia (OP). His smoking history and the PET pattern prioritised malignancy as a key differential diagnosis. The next step should be an attempt to obtain lung tissue for histopathological diagnosis. Because the lung lesion was not easily accessible, the decision was made to proceed to endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of the enlarged lymph nodes. Bronchoscopy with EBUS-TBNA of the lymph nodes in stations 4R, 4L and 7 was performed. The bronchoscopy findings were normal. Results of Gram and Ziehl–Neelsen stains on bronchoalveolar lavage fluid were negative. Cytological analysis of the lymph nodes revealed a neutrophilic cell infiltrate without malignant cells. Following multidisciplinary team discussion, a CT-guided, percutaneous, transthoracic needle biopsy of the left lower lobe mass was performed in order to rule out malignancy. Histological examination revealed thickening of the alveolar septa because of interstitial mononuclear inflammation, hyperplasia of type 2 cells and young, fibrotic, intra-alveolar plugs (figure 3).
Figure 3

Histological examination of the transthoracic needle biopsy specimen (haematoxylin and eosin staining, 200×).

Histological examination of the transthoracic needle biopsy specimen (haematoxylin and eosin staining, 200×).

Task 3

What is the final diagnosis and how would you manage this patient?

Answer 3

The histological pattern of this lesion resembled that of OP. Because no underlying aetiology or associated disorder was found, cryptogenic organising pneumonia (COP) is the most likely diagnosis. The management of COP has not been studied in prospective randomised trials, so treatment decisions are based on general clinical considerations including the severity of symptoms and the rapidity of disease progression. Corticosteroids are the current standard treatment, although the optimum dose and duration are less certain [1]. The patient was started on methylprednisolone 32 mg⋅day−1, which was gradually tapered, and stopped after 3 months. We observed a rapid clinical improvement and a gradual resolution of the abnormal CT findings on follow-up scans (figure 4).
Figure 4

Follow-up CT after a) 2 and b) 4 months showed marked improvement, with only a small, residual millimetric nodular lesion being present.

Follow-up CT after a) 2 and b) 4 months showed marked improvement, with only a small, residual millimetric nodular lesion being present.

Discussion

COP, the idiopathic form of OP, formerly called “bronchiolitis obliterans organising pneumonia”, is a well described entity with characteristic clinicoradiological features and pathological diagnostic criteria [2]. COP can present with a wide variety of radiological manifestations. Three main imaging patterns may be distinguished: Definitive diagnosis of COP relies on finding of typical pathological and clinical–radiologic features, and the exclusion of possible causes or associated disorders [3, 4]. multiple patchy alveolar opacities (typical pattern) a solitary focal lesion (focal pattern like in our case) diffuse bilateral infiltration Focal organising pneumonia (FOP) is a rare form of OP and presents as an isolated focal lesion on chest imaging, which may mimic lung cancer [5]. Only sporadic FOP cases or small case series have been reported in the literature. FOP accounts for approximately 10–15% of all cases of OP and the majority of cases are cryptogenic [6, 7]. Patients are usually asymptomatic or mildly symptomatic and it is more frequent in middle-aged male smokers [6-8]. Reported CT features of FOP show a wide range of variations, including solitary or multiple nodules or masses with irregular margins and a round or oval shape [9]. FOP lesions are predominantly located in the periphery of the lungs. Mediastinal lymphadenopathy involvement is an uncommon feature in OP. A retrospective study by Niimi et al. [10] showed that enlarged mediastinal nodes were present in 36% (eight out of 22) of the patients with COP. Usually, only one or two nodal stations are enlarged. Althoff Souza et al. [11] reported detectable enlargement in 38% (six out of 16) patients with COP. The presence of enlarged nodes was less common in COP than in the other idiopathic interstitial pneumonias (p=0.04). In the series of Zhao et al. [12], mild mediastinal lymph node enlargement was present in ∼20% of the patients. To our knowledge, three previous cases of OP presenting with extensive lymphadenopathy have been reported in literature [13-15]. OP is one of the benign thoracic conditions that may cause false positive results on PET-CT. Data on increased FDG uptake in OP are limited. In the series of Baha et al. [16], hypermetabolic activity of the focal lung lesion was demonstrated in all 14 FOP cases with a median maximal standardised uptake value (SUVmax) of 3.5±2.7 (range 2.1–13.1). Erdoğan et al. [17] demonstrated hypermetabolism on FDG-PET in all radiological subtypes of OP, with a mean SUVmax of the lesions calculated as 6.5. The diagnosis of FOP requires histopathological identification of a predominant pattern of OP, characterised by polypoid intraluminal plugs of proliferating fibroblasts and myofibroblasts within alveolar ducts and airspaces, with varying degrees of bronchiolar involvement [2-4]. Reports suggest that most patients underwent surgical resection of their lung lesion because of suspicion of lung cancer [7, 8, 12]. Although curative, pulmonary resection of FOP should be avoided, as it is unnecessary considering the benign nature of the disease and the efficacy of steroid therapy. CT-guided biopsy may be a valid alternative to more invasive procedures as shown in our case and in the series of Poulou et al. [18], where in all 14 patients, a single procedure yielded a diagnostic specimen. Rapid clinical and imaging improvement is usually obtained with corticosteroid therapy. The efficacy of steroids has been widely documented, and steroids continue to be recommended as the first choice of therapy for patients with symptomatic and progressive COP [1, 4]. The majority of patients recover completely with oral corticosteroids but relapse is common.

Conclusion

The combination of a FDG-PET-positive solitary lung nodule with significantly enlarged bilateral hilar and mediastinal lymph nodes, as observed in the present case, initially strongly suggested the diagnosis of locally advanced lung cancer. FDG-PET cannot differentiate FOP from a malignant tumour but it can help guide invasive procedures that should be performed when there is suspicion of malignancy. The presence of mediastinal lymphadenopathy has been very rarely reported in patients with COP. Finally, this case highlights the importance of obtaining histological confirmation of a suspicious pulmonary lesion, not only for establishing a definitive diagnosis but also for the planning of invasive surgical treatment or not.
  18 in total

1.  Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants.

Authors:  R H Lohr; B J Boland; W W Douglas; D H Dockrell; T V Colby; S J Swensen; P C Wollan; M D Silverstein
Journal:  Arch Intern Med       Date:  1997-06-23

2.  Feasibility of CT-guided percutaneous needle biopsy in early diagnosis of BOOP.

Authors:  Loukia S Poulou; Iris Tsangaridou; Petros Filippoussis; Nektaria Sidiropoulou; Sofia Apostolopoulou; Loukas Thanos
Journal:  Cardiovasc Intervent Radiol       Date:  2008-01-31       Impact factor: 2.740

3.  Cryptogenic organising pneumonia presenting with bilateral hilar and mediastinal lymphadenopathy.

Authors:  Hasan Kahraman; Mahmut Tokur; Hamide Sayar; Mehmet Fatih Inci
Journal:  BMJ Case Rep       Date:  2013-06-10

4.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

5.  CT features of focal organizing pneumonia: an analysis of consecutive histopathologically confirmed 45 cases.

Authors:  Feng Zhao; Sen-Xiang Yan; Gao-Feng Wang; Jin Wang; Pu-Xuan Lu; Bin Chen; Jing Yuan; Shi-Zheng Zhang; Yi-Xiang J Wang
Journal:  Eur J Radiol       Date:  2013-05-24       Impact factor: 3.528

6.  Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes.

Authors:  Fabien Maldonado; Craig E Daniels; Elizabeth A Hoffman; Eunhee S Yi; Jay H Ryu
Journal:  Chest       Date:  2007-09-21       Impact factor: 9.410

7.  Focal organizing pneumonia: CT appearance.

Authors:  N Kohno; J Ikezoe; T Johkoh; N Takeuchi; N Tomiyama; S Kido; H Kondoh; J Arisawa; T Kozuka
Journal:  Radiology       Date:  1993-10       Impact factor: 11.105

8.  Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients.

Authors:  Carolina Althoff Souza; Nestor L Müller; Kyung Soo Lee; Takeshi Johkoh; Hiromitsu Mitsuhiro; Semin Chong
Journal:  AJR Am J Roentgenol       Date:  2006-04       Impact factor: 3.959

9.  CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy.

Authors:  H Niimi; E Y Kang; J S Kwong; S Carignan; N L Müller
Journal:  J Comput Assist Tomogr       Date:  1996 Mar-Apr       Impact factor: 1.826

10.  The Evaluation of FDG PET/CT Scan Findings in Patients with Organizing Pneumonia Mimicking Lung Cancer.

Authors:  Yurdanur Erdoğan; Berna Akıncı Özyürek; Özlem Özmen; Nilgün Yılmaz Demirci; Sezgi Şahin Duyar; Yeliz Dadalı; Funda Demirağ; Jale Karakaya
Journal:  Mol Imaging Radionucl Ther       Date:  2015-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.